Disclosed are RAGE fusion proteins comprising RAGE polypeptide sequences linked to a second, non-RAGE polypeptide. The RAGE fusion protein may utilize a RAGE polypeptide domain comprising a RAGE ligand binding site and an interdomain linker directly linked to an immunoglobulin C<SUB>H</SUB>2 domain. Such fusion proteins may provide specific, high affinity binding to RAGE ligands. Also disclosed is the use of the RAGE fusion proteins as therapeutics for RAGE-mediated pathologies.
申请公布号
WO2007094926(A3)
申请公布日期
2007.10.18
申请号
WO2007US01686
申请日期
2007.01.23
申请人
TRANSTECH PHARMA, INC.;MJALLI, ADNAN, M., M.;WEBSTER, JEFFREY, C.;ROTHLEIN, ROBERT;TIAN, YE, E.
发明人
MJALLI, ADNAN, M., M.;WEBSTER, JEFFREY, C.;ROTHLEIN, ROBERT;TIAN, YE, E.